Darcy Mootz
Direttore/Membro del Consiglio presso ELEVATION ONCOLOGY, INC.
Patrimonio netto: - $ in data 30/06/2024
Profilo
Darcy Mootz is an Independent Director at Elevation Oncology, Inc. They previously worked as a Senior Director-Corporate Development at Achaogen, Inc., a Director at Alpha-9 Oncology, Inc., and as the Chief Business Officer at Oric Pharmaceuticals, Inc. Dr. Mootz completed their undergraduate degree at Duke University and their doctorate at Harvard University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ELEVATION ONCOLOGY, INC.
-.--% | 13/06/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Posizioni attive di Darcy Mootz
| Società | Posizione | Inizio |
|---|---|---|
| ELEVATION ONCOLOGY, INC. | Direttore/Membro del Consiglio | 18/01/2024 |
Precedenti posizioni note di Darcy Mootz
| Società | Posizione | Fine |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - |
| ACHAOGEN | Corporate Officer/Principal | - |
Formazione di Darcy Mootz
| Harvard University | Doctorate Degree |
| Duke University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ORIC PHARMACEUTICALS, INC. | Health Technology |
| ELEVATION ONCOLOGY, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Darcy Mootz
